| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 109 | 5.591 | 8.822 | 3.628 | 1.415 | 1.490 | 2.487 | 643 |
| Total Income - EUR | - | - | 109 | 5.591 | 11.406 | 5.861 | 1.588 | 1.491 | 2.487 | 646 |
| Total Expenses - EUR | - | - | 897 | 5.435 | 8.668 | 7.349 | 268 | 125 | 1.932 | 140 |
| Gross Profit/Loss - EUR | - | - | -788 | 156 | 2.738 | -1.488 | 1.320 | 1.366 | 554 | 506 |
| Net Profit/Loss - EUR | - | - | -789 | 110 | 2.642 | -1.524 | 1.279 | 1.327 | 479 | 430 |
| Employees | - | - | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Grizana Bio-Proiect Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | 60 | 289 | 3.231 | 1.263 | 1.751 | 3.098 | 3.631 | 4.059 |
| Inventories | - | - | 7 | 0 | 223 | 262 | 0 | 0 | 0 | 137 |
| Receivables | - | - | 0 | 71 | 1.791 | 724 | 1.557 | 3.082 | 708 | 704 |
| Cash | - | - | 54 | 217 | 1.217 | 278 | 195 | 16 | 2.924 | 3.219 |
| Shareholders Funds | - | - | -745 | -621 | 2.032 | 470 | 1.738 | 3.070 | 3.539 | 3.950 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 805 | 910 | 1.199 | 794 | 13 | 28 | 92 | 109 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7111 - 7111" | |||||||||
| CAEN Financial Year |
7111
|
|||||||||
Comments - Grizana Bio-Proiect Srl